Astrazeneca Pharma India standalone net profit rises 95.25% in the December 2024 quarter
Sales rise 43.98% to Rs 440.29 crore
Net profit of Astrazeneca Pharma India rose 95.25% to Rs 30.85 crore in the quarter ended December 2024 as against Rs 15.80 crore during the previous quarter ended December 2023. Sales rose 43.98% to Rs 440.29 crore in the quarter ended December 2024 as against Rs 305.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales440.29305.79 44 OPM %17.494.92 -PBDT84.6424.10 251 PBT75.5720.40 270 NP30.8515.80 95Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content